Solid Biosciences (SLDB) Capital Leases (2018 - 2024)
Solid Biosciences (SLDB) has disclosed Capital Leases for 7 consecutive years, with $307000.0 as the latest value for Q3 2024.
- Quarterly Capital Leases fell 77.46% to $307000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $307000.0 through Sep 2024, down 77.46% year-over-year, with the annual reading at $1.2 million for FY2023, 27.54% down from the prior year.
- Capital Leases hit $307000.0 in Q3 2024 for Solid Biosciences, down from $953000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $1.7 million in Q4 2022 to a low of $231000.0 in Q1 2022.
- Historically, Capital Leases has averaged $818470.6 across 5 years, with a median of $632000.0 in 2020.
- Biggest five-year swings in Capital Leases: surged 590.91% in 2023 and later tumbled 77.46% in 2024.
- Year by year, Capital Leases stood at $525000.0 in 2020, then tumbled by 44.19% to $293000.0 in 2021, then soared by 481.23% to $1.7 million in 2022, then fell by 27.54% to $1.2 million in 2023, then plummeted by 75.12% to $307000.0 in 2024.
- Business Quant data shows Capital Leases for SLDB at $307000.0 in Q3 2024, $953000.0 in Q2 2024, and $1.1 million in Q1 2024.